<DOC>
	<DOCNO>NCT01711489</DOCNO>
	<brief_summary>The purpose study assess effect multiple dose isavuconazole pharmacokinetics ( PK ) mycophenolate mofetil ( MMF ) single dose administration . Safety tolerability isavuconazole assess alone combination MMF .</brief_summary>
	<brief_title>A Study Assess Effect Multiple Doses Isavuconazole Pharmacokinetics Single Dose Mycophenolate Mofetil Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>The subject body weight least 45 kg body mass index ( BMI ) 18 32 kg/m2 , inclusive . Results aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) must ≤ 1.5 mg/dL The female subject agree sexual abstinence , surgically sterile , postmenopausal ( define least 2 year Screening without menses ) , use medically acceptable double barrier method ( e.g . spermicide diaphragm , spermicide condom ) prevent pregnancy agree continue use method Screening 5 week followup visit end study ; lactate pregnant document negative pregnancy test Screening Day 1 . The male subject agree sexual abstinence , surgically sterile , use medically acceptable method prevent pregnancy agree continue use method Screening 5 week followup visit end study The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probable cardiac cause ) . The subject history tuberculosis exposure anyone know suspected tuberculosis illness might confound result study pose additional risk administer study drug subject . The subject positive result hepatitis C antibody , hepatitis B surface antigen , QuantiFERON®TB Gold test Screening know positive human immunodeficiency virus ( HIV ) . The subject know suspect allergy component trial product include mycophenolate mofetil ( MMF ) azole class compound , history multiple and/or severe allergy drug food , history severe anaphylactic reaction . The subject smoker ( use tobacco nicotine containing product ) within 6 month prior Screening . The subject treatment prescription drug complementary alternative medicine within 14 day prior Day 1 , overthecounter medication within 1 week prior Day 1 , exception acetaminophen 2 g/day . The subject recent history ( within last 2 year ) drug alcohol abuse , define investigator , positive drug and/or alcohol screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>isavuconazole</keyword>
	<keyword>mycophenolate mofetil ( MMF )</keyword>
	<keyword>BAL8557</keyword>
	<keyword>BAL4815</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>Mycophenolic acid ( MPA )</keyword>
	<keyword>Phenolic glucuronide MPA ( MPAG )</keyword>
	<keyword>CellCept</keyword>
</DOC>